Our portfolio
InSphero
3D microtissues technology made affordable
InSphero is the leading supplier of organotypic 3D microtissues for efficacy testing and toxicology in drug development. 3D microtissues have a significantly higher biological relevance than standard cellular monolayers. More about InSphero.
Veeseo
Your Videos become searchable
At the moment, video content can only be discovered using manually created meta-data such as tags (keywords) and descriptions. This is a major problem for Video Content Owners. Normally, less than 1% of the actual spoken content is covered by existing meta-data, and it is impossible to search within videos. Veeseo has solved this problem with a sophisticated automatic keyword generation and transcription. More about Veeseo.
Poken
Collect people, places and things with a simple touch
Poken is a suite of NFC-based devices and social networking software that enable people to collect and exchange digital information in the real world with a simple touch. The Poken suite is fully brandable and is used for events, customer loyalty programs, and more to enable efficient networking, "paperless" data collection and lead generation. More about Poken.
Malcisbo
Sweet vaccines for safe & efficient food production
Malcisbo owns a proprietary target discovery platform which it uses in combination with glycoengineering technologies to design novel and efficient carbohydrate based vaccines. The glyocodiscovery platform is able to accommodate a wide variety of different pathogenic organisms, generating a constant outflow of novel vaccines against diseases that cannot be fought by conventional approaches. More about Malcisbo.
Ebuzzing (Wikio Group)
Social Networking News
Wikio offer web-users innovative web services to produce information, monetize it and identify the most useful content. They collaborate with a network of 30'000 european blogs to deliver the brand campaigns. More about Ebuzzing (Wikio Group).
Quest.li
Crowd-sourced smartphone games in real life
Questli provides a global web platform to build and play crowd-sourced games on smartphones. There are free and paid quests, players can win money or coupons from local promotions. Questli and game builders get a revenue share.[[SPLI More about Quest.li.
BiognoSYS
Proteomics Platform Technology
BiognoSYS has developed a paradigm shifting proteomics platform. It provides patented tools to enable faster discovery of biomarkers that will play a pivotal role in tomorrow's more personalized medicine. Biomarkers will accelerate the drug development process, provide better diagnosis, and allow patient specific treatment schemas. More about BiognoSYS.
Onsite-Lab
Onsite Lab provides best-in-class point of care diagnostics for unmet medical needs
Switzerland based Onsite Lab Holding AG is the majority shareholder of MedMira, the leading developer and manufacturer of rapid flow-through diagnostics and technologies. Providing today`s medical progress to customers from all over the world while combining the highest standard in quality with economical sustainability. More about Onsite-Lab.
Redbiotec
Technology Platform to Develop Virus Envelopes
Redbiotec provides a disruptive, patented technology platform to develop and produce "virus like particles" and other complex proteins. These particles enable big pharma to accelerate the development of novel vaccines against viral diseases such as pandemic flu, papilloma virus or seasonal influenza. More about Redbiotec.
Redalpine news
MedMira Strengthens Sales Distribution Channel in the US (15.05.2013)
MedMira (Redalpine Capital II), a leading developer and manufacturer of rapid diagnostic solutions, announced that it is strengthening the company’s sales and distribution channel in the United States by working directly with Cardinal Health and VWR International to sell and distribute the Reveal G3 Rapid HIV-1 Antibody Test.“Working directly with Cardinal and VWR to support [...] More.
Axel Springer AG signs global framework agreement with veeseo (02.05.2013)
Redalpine’s portfolio company veeseo reached an important milestone contributing to its international expansion plans. Veeseo’s Relevant Content Technology has proven itself on welt.de, where it is successfully in use since 2011. Therefore, Axel Springer AG has now decided to enter into a framework agreement with veeseo, which applies to all objects and holdings of the [...] More.
InSphero featured by Nature magazine and opens new offices in US (18.04.2013)
A technology feature in the last Nature issue on the subject of improving culture conditions for cells in vitro highlighted InSphero’s (Redalpine Capital I) 3D microtissue technology to make cells feel more “at home”. This overview of advances in cell culture technologies emphasizes the importance of the cellular environment including medium composition and 3D cellular [...] More.
